Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEU for AKI Diagnosis in Cirrhotic Patients
NCT02147470Unknown
- Sponsor
- University of Virginia
- Start
- Feb 2013
- Primary completion
- Dec 2015
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of perflutren lipid microspheres in acute kidney injury (AKI), sponsored by University of Virginia. Primary endpoint: Utility of monitoring of Renal Blood Flow using Contrast Enhanced Ultrasound. Status: unknown.
02
Drugs
perflutren lipid microspheres
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02147470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147470.